Aktie A2P0EP IMARA
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen IMARA

Aktien

A2P0EP

US45249V1070

IMRA

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Enliven Therapeutics Completes Merger With Imara
IMARA Inc.(NasdaqGS:IMRA) dropped from NASDAQ Composite Index
Enliven Therapeutics, Inc. completed the acquisition of IMARA Inc. from a group of shareholders for approximately $340 million in a reverse merger transaction.
IMARA INC. : Material Modification to Rights of Security Holders, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
Imara Announces Stockholder Approval of Merger With Enliven
Imara Announces Stockholder Approval of Merger With Enliven
IMARA INC. : Other Events (form 8-K)
IMARA INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
IMARA Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
IMARA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Imara Inc. - IMRA
Top Premarket Decliners
IMARA INC. : Other Events (form 8-K)
IMARA INC. Financial Statements and Exhibits (form 8-K/A)
IMARA INC. : Completion of Acquisition or Disposition of Assets, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
Cardurion Pharmaceuticals, LLC acquired Tovinontrine (IMR-687) and All of the Assets Related to PDE9 Program from IMARA Inc. for approximately $95.
IMARA INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
IMARA Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
IMARA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Imara Inc. - IMRA
Sector Update: Health Care Stocks Ending with Modest Declines
Sector Update: Health Care Stocks Sliding with Broader Friday Markets
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2P0EP Aktie
  4. Nachrichten IMARA
  5. Andere Sprachen